| 영문 | formula | 한글 | 처방 |
|---|---|---|---|
| 설명 | 병을 치료하기 위하여 증상에 따라 약을 짓는 방법, 즉, 숫자 또는 기타의 기호를 사용하여 화합물, 예컨대 의약품의 조성 또는 조제에 대하여 지시를 주며, 혹은 기대하는 값이나 결과를 얻기 위한 일정한 과정을 지시하는 표기. 의사-치과의사가 환자에 대하여 치료상 약제를 조제해서 투여할 필요가 있을 경우에는 질병 또는 증상의 예방-치료에 필요한 약물을 선택하여 그 조제법 및 사용법을 약사에게 지시하게 되는데 이 지시를 처방이라고 한다. |
||
| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| COLD | A cold agglutinin titer |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| OHI | Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In... |
| FF | formula fed |
|---|---|
| cs | 1(cold-sensitive |
| C | cold |
| COLD | Chronic Obstructive Lung Disease |
| CPT | Cold Pressor Test |
| aid to families with dependent children | Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the social security act, title IV, in the u.s. (12 Dec 1998) |
|---|---|
| arthritis in children | Arthritis is not just a problem for the retired. It can and does affect children in the form of juvenile/paediatric arthritis. (12 Dec 1998) |
| vaccination, children's | In the United States, it is recommended that all children receive vaccination against: - hepatitis b - diphtheria, tetanus, pertussis - haemophilus influenzae type b (hib), poliovirus, measles, mumps, rubella, varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| renal masses in children | <radiology> Hydronephrosis, obstructed duplication, multicystic dysplastic kidney, 2nd most frequent abdominal mass in the neonate, ureteropelvic atresia during metanephric intrauterine phase, 40% contralateral involvement, mesoblastic nephroma, most common newborn solid renal tumour, Wilms tumour, multiloculated cystic nephroma, multiple noncommunicating cysts (12 Dec 1998) |
| children's immunizations | In the United States, it is recommended that all children receive vaccination against: Hepatitis B, Diphtheria, tetanus, pertussis, Haemophilus influenzae type B (HIB), Poliovirus, Measles, mumps, rubella, Varicella zoster virus (chickenpox). Every child should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| disabled children | Children with mental or physical disabilities that interfere with usual activities of daily living and that may require accomodation or intervention. (12 Dec 1998) |
| immunization, children's | In the United States, it is recommended that all children receive vaccination against: hepatitis b diphtheria, tetanus, pertussis haemophilus influenzae type b (hib) poliovirus measles, mumps, rubella varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| linear IgA bullous disease in children | A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin. Synonym: linear IgA bullous disease in children. (05 Mar 2000) |
| Arneth formula | The normal, approximate ratio of polymorphonuclear neutrophils, based on the number of lobes in the nuclei, as follows: 1 lobe, 5%; 2 lobes, 35%; 3 lobes, 41%; 4 lobes, 17%; 5 lobes, 2%. (05 Mar 2000) |
| Bazett's formula | A formula for correcting the observed Q-T interval in the electrocardiogram for cardiac rate: corrected Q-T = Q-T sec/✓R -R sec. (05 Mar 2000) |
| Bernhardt's formula | <nutrition> A formula used to calculate the ideal weight, in kilograms, for an adult; it is the height in centimeters times the chest circumference in centimeters divided by 240. (14 Aug 2000) |
| Black's formula | A translation of Pignet's formula into British measurements: F = (W + C) -H; F is the empirical factor, W is the weight in pounds, C the chest girth in inches at full inspiration, and H the height in inches; a man is classed as very strong when F is over 120, strong between 110 and 120, good 100 to 110, fair 90 to 100, weak 80 to 90, very weak under 80. (05 Mar 2000) |
| Broca's formula | A fully developed man (30 years old) should weigh as many kilograms as he is centimeters in height over and above 1 meter. (05 Mar 2000) |
| Van Slyke's formula | The value obtained when the square root of the urine flow (when below 2 ml/min) is multiplied by the urine urea concentration and divided by the whole blood urea concentration; represents an old empirical adjustment for the effect of low urine flow on urea excretion; sometimes corrected for body size by dividing by some function of body weight or surface area. Later, plasma concentration was substituted for blood concentration in the calculation. The normal value is about 54 ml/min per 1.73 m2 in an adult person. Synonym: Van Slyke's formula. (05 Mar 2000) |
| Mall's formula | A formula for determining the age (in days) of a human embryo; calculated as the square root of its length (measured from vertex to breech) in millimeters multiplied by 100. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|